224
Citations
116
Journals
2007
First Cited
2022
Last Cited

Articles citing This Document (Page 1 of 5)

ArticleJournalYear
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment
Immunotherapy in biliary tract cancers: Current evidence and future perspectives2022
Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function2022
Dynamic Prediction of Survival After Curative Resection of Intrahepatic Cholangiocarcinoma: A Landmarking-Based AnalysisAnnals of Surgical Oncology
Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial Embolization: A Retrospective Study on Patterns, Treatments, and PrognosesAnnals of Surgical Oncology
Evaluation of abnormal gallbladder imaging findings: Surgical management and pathologic correlations in early‐stage gallbladder cancerClinical Case Reports (discontinued)2022
The second Mexican consensus on hepatocellular carcinoma. Part II: TreatmentRevista De Gastroenterología De México (English Edition)2022
Impact of bodyweight‐based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinomaHepatology Research
The Increasing Role of CT-Guided Cryoablation for the Treatment of Liver Cancer: A Single-Center ReportCancers2022
The Therapeutic Role of PNU-74654 in Hepatocellular Carcinoma May Involve Suppression of NF-κB SignalingMedicina (Lithuania)2022
Proton Therapy in the Management of Hepatocellular CarcinomaCancers2022
PET-CT in Clinical Adult Oncology: III. Gastrointestinal MalignanciesCancers2022
II Consenso mexicano de carcinoma hepatocelular. Parte II: tratamientoRevista De Gastroenterología De México2022
Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma.Cancers2022
In Reply to Nguyen et al.Practical Radiation Oncology2022
Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor ThrombosisCancers2022
Indirect Comparisons via Sorafenib for the Comparative Effectiveness of Two PD-1/PD-L1 Inhibitors to Treat Advanced Hepatocellular Carcinoma Patients without Prior Systemic Therapies.Clinical Epidemiology2022
The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment.Cancers2022
Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States.Cancer2022
The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients.Journal of Gastrointestinal Cancer2022
Association of County-Level Upward Economic Mobility with Stage at Diagnosis and Receipt of Curative-Intent Treatment among Patients with Hepatocellular Carcinoma.Annals of Surgical Oncology2022
Precision Medicine Targeting Genomic Alterations in Advanced Cholangiocarcinoma: Current State and Future Perspectives.Frontiers in Oncology2022
Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology.Frontiers in Oncology2022
ASO Author Reflections: Usage of Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma.Annals of Surgical Oncology2022
Impact of the Cancer and Aging Research Group score and treatment intensity on survival and toxicity outcomes in older adults with advanced noncolorectal gastrointestinal cancers.Cancer2022
Neoadjuvant and Adjuvant Therapy in Intrahepatic CholangiocarcinomaJournal of Clinical and Translational Hepatology2022
Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular Carcinoma.Frontiers in Oncology2022
Liver-Directed Treatment Options Following Liver Tumor Recurrence: A Review of the Literature.Frontiers in Oncology2022
Liver Transplantation for intrahepatic cholangiocarcinoma: ready for prime time?Hepatology2021
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma.Journal of Personalized Medicine2021
Survival following liver transplantation for locally-advanced, unresectable intrahepatic cholangiocarcinomaAmerican Journal of Transplantation2021
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control StudyHepatology Communications2021
Focal neuroendocrine carcinoma mixed with adenocarcinoma of the gallbladder with aggressive lymph node metastasis in a patient who did not meet the mixed neuroendocrine-non-neuroendocrine neoplasm criteriaClinical Journal of Gastroenterology2021
Surgical management of intrahepatic cholangiocarcinomaExpert Review of Anticancer Therapy2021
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice GuidelinePractical Radiation Oncology2021
Patterns of Recurrence and Its Effective Treatment2020
Benign and Malignant Tumors of the Liver2020
Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor ThrombosisCancers2021
Systemic therapy of hepatocellular carcinoma: reality and prospectsAnnals of HPB Surgery2020
Lenvatinib for large hepatocellular carcinomas with portal trunk invasion: Two case reportsWorld Journal of Clinical Cases2020
Regional Therapies in Hepatocellular Carcinoma and Cholangiocarcinoma2020
Second-line treatment of hepatocellular carcinoma: from theory to practical issuesMeditsinskiy Sovet2019
Screening for Gastrointestinal Cancers2019
Gallbladder Cancer: Current and Emerging Therapies2019
Transarterial Therapies2019
Staging and Prognosis2019
Hepatobiliary Malignancies2018
Role of Radiation Therapy in Hepatocellular Carcinoma2018
Liver
Benign and Malignant Tumors of the Liver2017